Research and development of Chinese anti-COVID-19 drugs

The outbreak and spread of coronavirus disease 2019 (COVID-19) highlighted the importance and urgency of the research and development of therapeutic drugs. Very early into the COVID-19 pandemic, China has begun developing drugs, with some notable progress. Herein, we summarizes the anti-COVID-19 dru...

Descripción completa

Detalles Bibliográficos
Autores principales: Ji, Xiwei, Meng, Xiangrui, Zhu, Xiao, He, Qingfeng, Cui, Yimin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472487/
https://www.ncbi.nlm.nih.gov/pubmed/36119967
http://dx.doi.org/10.1016/j.apsb.2022.09.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472487/
https://www.ncbi.nlm.nih.gov/pubmed/36119967
http://dx.doi.org/10.1016/j.apsb.2022.09.002

Ejemplares similares